Hence, due to its inhibitory effects on L-type calcium currents in cardiomyocytes, improvement of endothelial-dependent vasorelaxation in coronary arteries, and stimulation of PLC-mediated signaling, NPR-C activation might be of particular interest in the setting of cardiac ischemia. The gene discussed is HSPG2; the disease is myocardial ischemia.